About this trial
RECUPERA-C is a prospective observational pilot study evaluating the feasibility and safety of an early discharge strategy within 48 hours after minimally invasive colorectal surgery. The study will assess whether patients can meet predefined clinical and functional discharge criteria, and will identify factors that may prevent early discharge. C-reactive protein and neutrophil-to-lymphocyte ratio will also be evaluated as exploratory markers of postoperative complications.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years.
Elective major colorectal surgery for benign or malignant disease.
Minimally invasive approach (laparoscopic or robotic).
ASA physical status I-III.
Disqualifiers
Emergency surgery.
Significant intraoperative complications.
Major multivisceral resections.
New ostomy creation.
Trial population
The study population will consist of adult patients undergoing elective major minimally invasive colorectal surgery at the participating centre.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Proportion of patients fulfilling all predefined clinical and functional criteria for early discharge (≤48 hours after surgery)
Proportion of patients fulfilling all predefined clinical and functional criteria for early discharge (≤48 hours after surgery)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: